Cor Vasa 2021, 63(1):58-65 | DOI: 10.33678/cor.2020.021
The role of vitamin D in statin treated patients complaining of myalagia
- Cairo University, Egypt
Background: There is a multitude of evidence supporting the benefit of statin use in cardiovascular disease; however, statin-induced myopathy is a major reason for statin discontinuation and non-adherence. Vitamin D deficiency has been independently associated with muscle weakness and severe myopathy, and may be a confounder for statin-induced myopathies.
Objectives: To determine whether low serum vitamin D is associated with the occurrence of myalgia in statin treated patients.
Patients and methods: This cross-sectional study enrolled 60 statin-treated patients. Patients were divided into two groups each was formed of 30 patients. Group 1 enrolled patients taking statins and suffering from myalgia, while group 2 enrolled patients on statins yet free of muscle pains.
Results: The duration of myalgia in symptomatic patients was (5.03±2.4 weeks). Statin Myalgia Clinical Index score in myalgic patients ranged between 9 to 11. The current study found a significant association between low serum vitamin D level and myalgia in statin treated patients. Patients with statin-associated myalgia had significantly lower levels of vitamin D compared to asymptomatic patients (29.3±12.4 vs. 97.4±15.1 nmol/mL, p < 0.001).
Conclusion: This study provided suggestive evidence that there is an association between plasma vitamin D levels and statin-associated myalgia. Patients with statin-associated myalgia had significantly lower levels of vitamin D compared to asymptomatic patients. Vitamin D levels may be useful for the diagnosis and management of statin-associated muscle symptoms.
Keywords: Myalgia, Statins, Vitamin D
Received: December 9, 2019; Revised: March 16, 2020; Accepted: March 26, 2020; Published: February 25, 2021 Show citation
References
- Pennisi M, Di Bartolo G, Malaguarnera G, et al. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402.
Go to original source...
Go to PubMed...
- Joy TR, Hegele RA. Narrative review: Statin-related myopathy. Ann Intern Med 2009;50:858-868.
Go to original source...
Go to PubMed...
- Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf 2011;10:373-387.
Go to original source...
Go to PubMed...
- Sathasivam S. Statin induced myotoxicity. Eur J Intern Med 2012;23:317-324.
Go to original source...
Go to PubMed...
- Thompson PD, Clarkson P, Karas RH. Statin-Associated Myopathy. J Am Med Assoc 2003;289:1681-1690.
Go to original source...
Go to PubMed...
- Gupta A, Thompson PD. The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 2011;215:23-29.
Go to original source...
Go to PubMed...
- Pasanen MK, Fredrikson H, Neuvonen PJ, et al. Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. Clin Pharmacol Ther 2007;82:726-733.
Go to original source...
Go to PubMed...
- Needham M, Mastaglia FL. Statin myotoxicity: a review of genetic susceptibility factors. Neuromuscul Disord 2014;24:4-15.
Go to original source...
Go to PubMed...
- Zuccaro P, Mombelli G, Calabresi L, et al. Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin. Pharmacol Res 2007;55:310-317.
Go to original source...
Go to PubMed...
- Ghatak A, Faheem O, Thompson PD. The genetics of statin-induced myopathy. Atherosclerosis 2010;210:337-343.
Go to original source...
Go to PubMed...
- Oh J, Ban MR, Miskie BA, et al. Genetic determinants of statin intolerance. Lipids Health Dis 2007;6:7.
Go to original source...
Go to PubMed...
- Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 2006;80:565-581.
Go to original source...
Go to PubMed...
- Mancini GB, Tashakkor AY, Baker S, et al. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. Can J Cardiol2013;29:1553-1568.
Go to original source...
Go to PubMed...
- Taşoğlu Ö, Kutsal YG, Taşoğlu İ, et al. Is Vitamin D Deficiency a Risk Factor for the Development of Statin-Induced Myalgia in Patients Receiving Statins? Turk J Phys Med Rehab 2015;61:314-319.
- Wallis DE, Penckofer S, Sizemore GW. The "Sunshine Deficit" and Cardiovascular Disease. Circulation 2008;118;1476-1485.
Go to original source...
Go to PubMed...
- Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1,25-dihydroxyvitamin D3receptor in human skeletal muscle tissue. Histochem J 2001;33:19-24.
Go to original source...
Go to PubMed...
- Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002;13:187-194.
Go to original source...
Go to PubMed...
- Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al. American College of Cardiology, American Heart Association, National Heart, Lung and Blood Institute. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Circulation 2002;106:1024-1028.
Go to original source...
Go to PubMed...
- Rosenson RS, Baker SK, Jacobson TA, et al. The National Lipid Association's Muscle Safety Expert Panel. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol 2014;8(3 Suppl):S58-S71.
Go to original source...
Go to PubMed...
- Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy - European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 2015;36:1012-1022.
Go to original source...
Go to PubMed...
- Keech A, Collins R, Macmahon S, et al. Three-year follow-up of the Oxford cholesterol study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J 1994;15:255-269.
Go to original source...
Go to PubMed...
- Richardson K, Schoen M, French B, et al. Statins and Cognitive Function: A Systematic Review. Ann Intern Med 2013;159:688-697.
Go to original source...
Go to PubMed...
- Rosenson RS, Miller K, Bayliss M, et al. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability. Cardiovasc Drugs Ther 2017;31:179-186.
Go to original source...
Go to PubMed...
- Ogden CL, Fryar CD, Carroll MD, Flegal KM. Mean body weight, height, and body mass index, United States 1960-2002. Adv Data 2004;(347):1-17.
- Abbott ARCHITECT® 25-OH Vitamin D Assay [directional insert 3L52, G2-3231/R03]. Abbott Laboratories, Abbott Park, IL, USA 2011.
- Jacques PF, Felson DT, Tucker KL, et al. Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr 1997;66:929-936.
Go to original source...
Go to PubMed...
- Harper CR, Jacobson TA. The broad spectrum of statin myopathy: From myalgia to rhabdomyolysis. Curr Opin Lipidol 2007;18:401-408.
Go to original source...
Go to PubMed...
- Riche KD, Arnall J, Rieser K, et al. Impact of vitamin D status on statin-induced myopathy. J Clin Transl Endocrinol 2016;6:56-59.
Go to original source...
Go to PubMed...
- Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (
- Minissian M, Agarwal M, Shufelt C, et al. Do women with statin-related myalgias have low Vitamin D levels? BMC Res Notes 2015;8:6-10.
Go to original source...
Go to PubMed...
- Daniel K, Israel H, Janet V, et al. Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf) 2012;77:36-41.
Go to original source...
Go to PubMed...
- Melissa B, Zena S, Keith C, et al. Vitamin D induces myogenic differentiation in skeletal muscle derived stem cells. Endocr Connect 2017;6:139-150.
Go to original source...
Go to PubMed...
- Kang J, Nguyen Q, Mutka J, Le QA. Rechallenging statin therapy in veterans with statin-induced myopathy post vitamin D replenishment. J Pharm Pract 2017;30:521-527.
Go to original source...
Go to PubMed...
- Khayznikov M, Hemachrandra K, Pandit R, et al. Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation. North Am J Med Sci 2015;7:86-93.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.